Blanket Purchase Agreement GS35F386DA-75F40124A00009

Award Date 8/26/24
Last Date to Order 8/26/29
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) contract to Booz Allen Hamilton Inc., a leading government services provider, for a range of professional services to support the agency's business operations and modernization initiatives. The contract has a total ceiling value of $149,000,000 and an ultimate completion date of March 26, 2028. Under this BPA, Booz Allen Hamilton will provide the FDA with technical and management consulting services to support...
The Blanket Purchase Agreement was awarded by the Department of Health and Human Services Food and Drug Administration to Booz Allen Hamilton Inc. as a single-award contract vehicle under the Multiple Award Schedule contracting vehicle. With a potential value of $90 million and a period of performance through October 2026, the BPA aims to procure scientific services in support of EO 14042 as described in the contract description. The BPA establishes an indefinite delivery/indefinite quantity...
This Blanket Purchase Agreement (BPA) contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the prime contractor Booz Allen Hamilton Inc., a prominent management and technology consulting firm. The contract has a ceiling value of $100,000,000 and a period of performance through July 31, 2027. The contract vehicle is the General Services Administration's (GSA) Multiple Award Schedule (MAS). The BPA contract is for Next Generation Regulatory Business Information...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services to the U.S. government. The $80 million, single-award contract utilizes the General Services Administration's (GSA) Multiple Award Schedule (MAS) contract vehicle and does not have a set-aside designation. Under this BPA, Booz Allen Hamilton will provide the FDA with a wide...
This Blanket Purchase Agreement (BPA) contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to Booz Allen Hamilton Inc., a prominent government contracting firm. The contract has a ceiling value of $90,000,000 and a period of performance through July 7, 2025. The contract is for "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES" to support the FDA. As a BPA, it provides a streamlined procurement mechanism for the agency to efficiently obtain a range of...
The Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) under the Multiple Award Schedule (MAS) contract vehicle to Booz Allen Hamilton Inc. to provide FDA Data Dashboards and Analytics services. The $15 million BPA, which has no set-aside designation, will support the use, implementation, and operation of a dashboard solution for the FDA over a period ending in August 2028. Two task orders have been issued under this BPA to date: The first task order, valued at...
The Department of Health and Human Services' Food and Drug Administration awarded a Blanket Purchase Agreement to Booz Allen Hamilton Inc. to provide various information technology services in support of FDA programs. Under the BPA, three call contracts have been issued totaling over $35 million. The first call awarded Booz Allen a $221,556 contract to analyze IT needs and develop a roadmap for FDA's laboratory operations over six months. A second call valued at $9.2 million retains Booz Allen...
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a prominent management, technology, and engineering services firm. The BPA has a ceiling value of $150,000,000 and a period of performance through December 17, 2025. The BPA supports the FDA's CTP BPA IT Systems Lifecycle Development and Management Support program, under which Booz Allen Hamilton has been awarded several task orders. These task orders...
The Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services, to provide Regulatory Review Support Services. The master BPA has a ceiling value of $163,000,000 and a period of performance through March 2025. Under this BPA, the FDA has issued multiple task orders to Booz Allen Hamilton for services related to the Advanced Information Retrieval Research System (AIRRS),...
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA) to Accenture Federal Services LLC, a subsidiary of the global professional services firm Accenture plc. The BPA, titled "Modernizing FDA Data and Analytics," has a total ceiling value of $500,000,000 and an ultimate completion date of August 26, 2029. The BPA is intended to provide the FDA with a wide range of IT, consulting, and technology services to support the agency's data and analytics...

This Blanket Purchase Agreement (BPA) is a multiple award IDV (Indefinite Delivery Vehicle) awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc. The contract is part of the "Modernizing FDA Data and Analytics" program, with a total ceiling value of $500,000,000 and a period of performance through August 26, 2029.

Booz Allen Hamilton, a prominent management and technology consulting firm, will provide a wide range of professional services to the FDA under this BPA, including IT infrastructure support, cybersecurity, data analytics, program management, systems engineering, research and development, and technical assessment. The company has a strong track record of federal contract awards across multiple agencies and domains, leveraging contract vehicles such as the Multiple Award Schedule (MAS), Seaport Next Generation, and One Acquisition Solution for Integrated Services (OASIS). This BPA allows the FDA to efficiently procure these services through task orders issued under the agreement.

Generated 5/6/25, 9:52 AM